What will that mean to us Ginger?
- Forums
- ASX - By Stock
- NEU
- Ann: Rett Syndrome NDA accepted for Priority Review by FDA
NEU
neuren pharmaceuticals limited
Add to My Watchlist
0.66%
!
$14.46

Ann: Rett Syndrome NDA accepted for Priority Review by FDA, page-4
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$14.46 |
Change
0.095(0.66%) |
Mkt cap ! $1.812B |
Open | High | Low | Value | Volume |
$14.49 | $14.61 | $14.32 | $1.209M | 83.45K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 71 | $14.45 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$14.46 | 259 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 156 | 14.520 |
3 | 244 | 14.510 |
8 | 703 | 14.500 |
7 | 1263 | 14.490 |
4 | 1091 | 14.480 |
Price($) | Vol. | No. |
---|---|---|
14.540 | 235 | 6 |
14.550 | 683 | 6 |
14.560 | 1226 | 6 |
14.570 | 1222 | 5 |
14.580 | 1078 | 5 |
Last trade - 12.28pm 15/07/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
CC9
CHARIOT CORPORATION LTD
Shanthar Pathmanathan, MD
Shanthar Pathmanathan
MD
Previous Video
Next Video
SPONSORED BY The Market Online